Articles about IPO

The little chips that could: How Impinj has survived 26 years in a market that’s ‘just getting going’

More than a quarter-century after Impinj was founded, CEO Chris Diorio and team rang the Nasdaq opening bell Tuesday to mark the Seattle RFID chipmaker’s 10th anniversary as a public company. GeekWire chronicles the company’s ups and downs, and what’s next. Read More

General Fusion set to become the first publicly traded fusion stock on a major exchange

British Columbia-based General Fusion on Friday completed its deal to become first publicly traded fusion stock on a major exchange.… Read More

SpaceX leapfrogs Amazon and briefly tops Microsoft in market value on Cursor acquisition news

Shares of SpaceX surged Tuesday, pushing the Elon Musk-led company above Amazon and into a neck-and-neck race with Microsoft for the title of the world’s fourth-most valuable public company less than a week after its blockbuster $75 billion IPO. Read More

Opinion: SpaceX is no Tesla

Seattle AI veteran Oren Etzioni argues that SpaceX’s record-setting IPO valuation prices in three unproven bets at once — and that the Tesla playbook doesn’t apply at this starting point. Read More

Still ringing a bell: F5 marks its 30th year in business

Seattle-based F5 marked 30 years in business Friday by ringing the Nasdaq opening bell. The application-delivery and security company has grown to $3.1 billion in annual revenue and outlived nearly all the marquee customers and the three investment banks listed in its 1999 IPO prospectus. Read More

SpaceX is churning out 70 Starlink satellites a week in Redmond, and other tidbits from its IPO filing

SpaceX disclosed in its S-1 filing that its Redmond, Wash., facility produces approximately 70 Starlink satellites per week, putting hard production numbers on the operation for the first time. The filing also reveals Starlink’s financials and names several Pacific Northwest companies as competitors. Read More

IPO

The little chips that could: How Impinj has survived 26 years in a market that’s ‘just getting going’

General Fusion set to become the first publicly traded fusion stock on a major exchange

SpaceX leapfrogs Amazon and briefly tops Microsoft in market value on Cursor acquisition news

Opinion: SpaceX is no Tesla

Still ringing a bell: F5 marks its 30th year in business

SpaceX is churning out 70 Starlink satellites a week in Redmond, and other tidbits from its IPO filing

Kestra Medical Technologies raises $202M in IPO, prices shares above expected range

Kestra Medical Technologies, maker of wearable cardiac devices, files for IPO

Will any Seattle startups go public this year? Analysts see better climate for tech IPOs

Industrial headset maker RealWear to go public via SPAC with Seattle investment bank

Exit comeback: After big slowdown in IPO and M&A activity, analysts optimistic for a rebound

Buyers wanted: Exit opportunities for venture-backed startups sharply decline amid downturn

Amazon-backed electric vehicle maker Rivian races to huge stock market debut after IPO

‘Fall in love with a problem’: Remitly CEO reflects on startup journey as remittance company goes public

Remitly prices IPO at $43/share; Seattle fintech giant valued at nearly $7B

Remitly aims to raise up to $332M at $6.5B valuation in IPO for Seattle fintech giant

Money transfer startup Remitly reveals financial results in preparation for upcoming IPO

Amazon-backed electric vehicle maker Rivian files to go public at reported $80B valuation

From hackathon to IPO: Pet sitting marketplace Rover is Seattle’s newest public company

Icosavax stock skyrockets 200% on first day of trading for newly public Seattle biotech company

Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B

Eliem Therapeutics files for IPO as another Seattle-area biotech firm set to go public

Vancouver, Wash. biotech company Absci files to go public

Remitly files initial IPO paperwork as Seattle fintech company prepares to go public

Impel Neuropharma raises $80M in Washington state’s first IPO of 2021

Seattle biotech firm Impel NeuroPharma files for $75M IPO

Qualtrics raises $1.55 billion in IPO, spinning out from SAP with plans to continue Seattle growth

Silverback Therapeutics prices IPO at $21/share, will raise $241M in 4th Wash. state IPO of 2020

Seattle biotech firm Silverback Therapeutics sets terms for IPO, looks to raise up to $151M

With deep roots in Seattle, real estate brokerage Compass reportedly eyes IPO